Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 22, 2022
Project Confirm: Accelerated Drug Approvals for Chronic Myeloid LeukemiaKendra L Sweet, Jorge E Cortes, Jane F Apperley, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2015
FDA approval: idelalisib monotherapy for the treatment of patients with follicular lymphoma and small lymphocytic lymphomaBarry W Miller, Donna Przepiorka, R Angelo de Claro, et al.Cytotherapy|February 27, 2022
Need for aligning the definition and reporting of cytokine release syndrome (CRS) in immuno-oncology clinical trialsMark D Stewart, Bruce McCall, Marcelo Pasquini, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2025
US Food and Drug Administration Approval Summary: Imetelstat for Selected Patients With Low- to Intermediate-1 Risk Myelodysplastic Syndromes With Transfusion-Dependent AnemiaNina Kim, E Dianne Pulte, Lori A Ehrlich, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2025
FDA Approval Summary: Axatilimab for Adult and Pediatric Patients Weighing at Least 40 Kilograms with Chronic GVHD after Two Prior Lines of Systemic TherapyRobert Q Le, Kamar Godder, Jingyan Wang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2022
FDA Approval Summary: Belumosudil for Adult and Pediatric Patients 12 Years and Older with Chronic GvHD after Two or More Prior Lines of Systemic TherapyDonna Przepiorka, Robert Q Le, Alexei Ionan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2021
Subgroup Analyses in Oncology Trials: Regulatory Considerations and Case ExamplesAnup K Amatya, Mallorie H Fiero, Erik W Bloomquist, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2015
FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic LeukemiaR Angelo de Claro, Karen M McGinn, Nicole Verdun, et al.Cancer Discovery|December 12, 2023
Highlights of FDA Oncology Approvals in 2023: Bispecific T-cell Engagers, Pediatric Indications, and Inclusive Drug DevelopmentJoshua M Donaldson, Marjilla Seddiq, Michael J Fusco, et al.Therapeutic Innovation & Regulatory Science|April 18, 2023
Comparative Expedited Regulatory Programs of U.S Food & Drug Administration and Project Orbis PartnersLauren T Hotaki, Anu Shrestha, Monica P Bennett, et al.Pageof 6